SIGN UPLog In

Last deal

$50.M

Amount

Series A

Stage

23.08.2005

Date

1

all rounds

$50.M

Total amount

General

About Company
Cerexa is a biopharmaceutical company developing novel anti-infective therapies for serious infections.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2005

Number of employees

5001-10000

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Cerexa focuses on the development of Ceftaroline Acetate, an injectable cephalosporin used to treat bacterial infections caused by gram-positive and gram-negative pathogens.
Contacts

location

New York, NY, USA

Phone number

Social url